These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 494264)

  • 21. Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat.
    Walker D; Carrington A; Cannan SA; Sawicki D; Sredy J; Boulton AJ; Malik RA
    J Anat; 1999 Oct; 195 ( Pt 3)(Pt 3):419-27. PubMed ID: 10580857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.
    Ling Q; Liu M; Wu MX; Xu Y; Yang J; Huang HH; Yu CX
    Biol Pharm Bull; 2014; 37(5):858-64. PubMed ID: 24790009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of insulin treatment on myelinated nerve fibre maturation and integrity and on body growth in streptozotocin-diabetic rats.
    Sharma AK; Duguid IG; Blanchard DS; Thomas PK
    J Neurol Sci; 1985 Mar; 67(3):285-97. PubMed ID: 3989572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
    Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
    Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental diabetic neuropathy. Morphometric studies on the rat N. suralis in short-term streptozotocin-induced diabetes].
    Wattig B; Warzok R; Thomas PK
    Zentralbl Allg Pathol; 1986; 131(5):451-8. PubMed ID: 3526747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathic changes associated with insulin treatment of diabetic rats: electron microscopic and morphometric analysis.
    Mandelbaum JA; Felten DL; Westfall SG; Newlin GE; Peterson RG
    Brain Res Bull; 1983 Mar; 10(3):377-84. PubMed ID: 6850362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distal neuropathy in experimental diabetes mellitus.
    Brown MJ; Sumner AJ; Greene DA; Diamond SM; Asbury AK
    Ann Neurol; 1980 Aug; 8(2):168-78. PubMed ID: 7425570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental diabetes in neonatal mice induces early peripheral sensorimotor neuropathy.
    Ariza L; Pagès G; García-Lareu B; Cobianchi S; Otaegui PJ; Ruberte J; Chillón M; Navarro X; Bosch A
    Neuroscience; 2014 Aug; 274():250-9. PubMed ID: 24846610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation.
    Lauria G; Lombardi R; Borgna M; Penza P; Bianchi R; Savino C; Canta A; Nicolini G; Marmiroli P; Cavaletti G
    J Peripher Nerv Syst; 2005 Jun; 10(2):202-8. PubMed ID: 15958131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Tongmai Jiangtang Capsule on Experimental Diabetic Peripheral Neuropathy Rats].
    Yang WQ; Yu YB; Xu XL; Ren HX; Zhang L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):831-834. PubMed ID: 30634211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
    Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK
    Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H; Sonobe M; Hatanaka I; Yamashita M; Miyamoto Y; Terada M; Amenomori M; Kikkawa R; Shigeta Y; Motoyama Y
    Biochem Biophys Res Commun; 1988 Jan; 150(1):225-30. PubMed ID: 3276309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
    Yagihashi S; Wada R; Kamijo M; Nagai K
    Lab Invest; 1993 Mar; 68(3):296-307. PubMed ID: 8383778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies.
    Yagihashi S; Tonosaki A; Yamada K; Kakizaki M; Goto Y
    Tohoku J Exp Med; 1982 Sep; 138(1):39-48. PubMed ID: 7147233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of diabetic neuropathy by investigating CNFL and IENFD in thy1-YFP mice.
    Leckelt J; Guimarães P; Kott A; Ruggeri A; Stachs O; Baltrusch S
    J Endocrinol; 2016 Nov; 231(2):147-157. PubMed ID: 27601446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
    Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B
    Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy.
    Parry GJ; Kozu H
    Neurology; 1990 Sep; 40(9):1446-9. PubMed ID: 2392233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.